EIF2AK3 and metabolic dysfunction-associated steatotic liver disease: Moreover, inhibition of the PERK/AFT4/CHOP signaling pathway with celastrol treatment protected mouse hepatocytes and prevented the progression of MASLD induced by a high-fat diet [41].